 |
|
 |
 |
|
|
Financial Information
| |
2008
|
2007 |
2006 |
2005 |
Revenues |
10,264,000 |
8,126,000 |
6,912,000 |
4,838,000 |
EBITDA |
1,020,000 |
1,504,000 |
1,049,000 |
401,000 |
Net Income (loss) |
(4,785,000) |
(2,677,000) |
(886,000) |
(1,768,000) |
|
|
|
|
|
Assets |
14,357,000 |
13,636,000 |
8,113,000 |
7,297,000 |
Liabilities |
6,262,000 |
5,927,000 |
5,177,000 |
9,938,000 |
Equity |
8,095,000 |
7,707,000 |
2,937,000 |
(2,640,000) |
|
|
|
|
|
Operating Cash Flow |
(391,000) |
(1,605,000) |
5,000 |
(201,000) |
Investing Cash Flow |
(158,000) |
(3,525,000) |
(369,000) |
(82,000) |
Financing Cash Flow |
435,000 |
4,913,000 |
1,059,000 |
512,000 |
Amounts expressed in Canadian Dollars |
Annual Reports
|
Q1 ended
August 31, 2008 |
Q2 ended
November 30,
2008 |
Q3 ended
February 29, 2009
|
Revenues |
|
|
|
EBITDA |
|
|
|
Net Income (loss) |
|
|
|
|
|
|
|
Assets |
|
|
|
Liabilities |
|
|
|
Equity |
|
|
|
|
|
|
|
Operating Cash Flow |
|
|
|
Investing Cash Flow |
|
|
|
Financing Cash Flow |
|
|
|
Amounts expressed in Canadian Dollars |
| 2009 |
2008 |
2007 |
2006 |
Third Quarter Ending February 29, 2009
- MD&A |
Third Quarter Ending February 29, 2008
- MD&A |
Third Quarter Ending February 28, 2007
- MD&A |
Third Quarter Ending February 28, 2006
- MD&A |
Second Quarter Ending November 30, 2008
- MD&A |
Second Quarter Ending November 30, 2007
- MD&A |
Second Quarter Ending November 30, 2006
- MD&A |
Second Quarter Ending November 30, 2005
- MD&A |
First Quarter Ending August 31, 2008
- MD&A |
First Quarter Ending August 31, 2007
- MD&A |
First Quarter Ending August 31, 2006
- MD&A |
First Quarter Ending August 31, 2005
- MD&A |
|
| Site Map | Disclaimer |
© Neptune Technologies & Bioressources Inc. - All Rights Reserved
Laval, Quebec |
|
